TransCode Therapeutics, Inc. Common Stock
$1.70
-$0.02 (-1.16%)
$1.67Day Range$2.00
Key Statistics
Market Cap
$29.12M
Shares Outstanding
16.9M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jul 9, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$2.00
Day High
$2.00
Day Low
$1.67
Volume
19.5K
VWAP
$1.73
Prev Close
$1.72
Transactions
--
Acc. Volume
--
About TransCode Therapeutics, Inc. Common Stock
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.
PHARMACEUTICAL PREPARATIONSSIC 283412 employees6 LIBERTY SQUARE, BOSTON, MA, 02109857-301-6857IPO Jul 9, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001829635
- Composite FIGI
- BBG00ZGYHV03
- Share Class FIGI
- BBG00ZGYHVW8
- Ticker Root
- RNAZ
- SIC Code
- 2834
About TransCode Therapeutics, Inc. Common Stock (RNAZ) Stock
TransCode Therapeutics, Inc. Common Stock (RNAZ) closed the 2026-09-18 session at $1.70, down 1.16% versus the previous close (-0.02). The stock opened at $2.00 and traded between $1.67 and $2.00 during that session. Session trading volume was 19K shares. The volume-weighted average price (VWAP) is $1.73.
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.
TransCode Therapeutics, Inc. Common Stock has a market capitalization of $29.1 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. RNAZ is listed on the XNAS exchange. The company employs approximately 12 people. TransCode Therapeutics, Inc. Common Stock is headquartered in BOSTON, MA. The recorded listing date is 2021-07-09.
On this page you can find market RNAZ stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.